Ask AI
ProCE Banner Activity

Improving Patient Outcomes in HAE Care: Expert Takeaways to Your Frequently Asked Questions

Clinical Thought

Learn how to address disease burden and persistent unmet needs in patients with hereditary angioedema (HAE), including shared decision-making strategies that can be used with patients and their families to help you provide personalized, guideline-concordant care in HAE.

Released: February 17, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Target Audience

This activity is intended for allergy/immunology healthcare professionals and others who care for patients with HAE, including physicians, residents, fellows, nurse practitioners, and physician associates.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Collaborate with patients to identify barriers and promote improved adherence and acceptance of long-term prophylaxis in HAE

Disclosure

Primary Author

Marc Riedl, MD, MS: researcher: Astria, Biocryst, BioMarin, CSL Behring, Intellia, Ionis, Kalvista, Pharvaris, Takeda; consultant/advisor/speaker: Astria, BioCryst, BioMarin, Celldex, CSL Behring, Cycle Pharma, Grifols, Intellia, Ionis, Kalvista, Novartis, Pharming, Pharvaris, Sanofi/Regeneron, Takeda.